Literature DB >> 15139498

Acute cholestatic hepatitis associated with long-term use of rofecoxib.

Georgios I Papachristou1, Anthony J Demetris, Mordechai Rabinovitz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15139498     DOI: 10.1023/b:ddas.0000020503.92146.8b

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  10 in total

1.  Celecoxib-induced acute pancreatitis and hepatitis: a case report.

Authors:  R Carrillo-Jimenez; M Nurnberger
Journal:  Arch Intern Med       Date:  2000-02-28

2.  Celecoxib-induced cholestatic hepatitis.

Authors:  M V Galan; S C Gordon; A L Silverman
Journal:  Ann Intern Med       Date:  2001-02-06       Impact factor: 25.391

Review 3.  Acute hepatocellular and cholestatic injury in a patient taking celecoxib.

Authors:  S Nachimuthu; L Volfinzon; L Gopal
Journal:  Postgrad Med J       Date:  2001-08       Impact factor: 2.401

4.  Drug Points: Cholestatic hepatitis in association with celecoxib.

Authors:  J P O'Beirne; S R Cairns
Journal:  BMJ       Date:  2001-07-07

5.  Celecoxib-induced cholestatic hepatotoxicity in a patient with cirrhosis.

Authors:  Paulo Alegria; Luís Lebre; Cristina Chagas
Journal:  Ann Intern Med       Date:  2002-07-02       Impact factor: 25.391

6.  Rofecoxib-induced cholestatic hepatitis: treatment with molecular adsorbent recycling system (MARS).

Authors:  Dominik Huster; Christian Schubert; Frieder Berr; Joachim Mössner; Karel Caca
Journal:  J Hepatol       Date:  2002-09       Impact factor: 25.083

Review 7.  Drug-induced liver disorders: implications for drug development and regulation.

Authors:  N Kaplowitz
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 8.  The hepatic safety and tolerability of the novel cyclooxygenase-2 inhibitor celecoxib.

Authors:  W C Maddrey; C J Maurath; K M Verburg; G S Geis
Journal:  Am J Ther       Date:  2000-05       Impact factor: 2.688

Review 9.  Rofecoxib.

Authors:  L J Scott; H M Lamb
Journal:  Drugs       Date:  1999-09       Impact factor: 9.546

10.  Acute cholestatic hepatitis associated with celecoxib.

Authors:  Antonio Grieco; Luca Miele; Andrea Giorgi; Ignazio M Civello; Giovanni Gasbarrini
Journal:  Ann Pharmacother       Date:  2002-12       Impact factor: 3.154

  10 in total
  3 in total

Review 1.  Non-steroidal anti-inflammatory drugs: What is the actual risk of liver damage?

Authors:  Fernando Bessone
Journal:  World J Gastroenterol       Date:  2010-12-07       Impact factor: 5.742

2.  Rofecoxib-induced hepatotoxicity: a forgotten complication of the coxibs.

Authors:  Brian Yan; Yvette Leung; Stefan J Urbanski; Robert P Myers
Journal:  Can J Gastroenterol       Date:  2006-05       Impact factor: 3.522

3.  Celecoxib-induced cholestatic liver failure requiring orthotopic liver transplantation.

Authors:  Ihab I El Hajj; Shahid M Malik; Hany R Alwakeel; Obaid S Shaikh; Eizaburo Sasatomi; Hossam M Kandil
Journal:  World J Gastroenterol       Date:  2009-08-21       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.